跳至主要内容
临床试验/EUCTR2010-019933-89-GB
EUCTR2010-019933-89-GB进行中(未招募)不适用

Investigation of a low dose Iohexol infusion for the measurement of Glomerular Filtration Rate (GFR) in adult volunteers and patients with Chronic Kidney Disease. - Iohexol infusion as a measure of GFR

St. George's, University of London0 个研究点目标入组 35 人开始时间: 2010年8月6日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Healthy volunteers – aged between 18 years and 75 years.
  • 2. Patients with established stable CKD from stages 1-4.
  • 3. All volunteers must have a Body Mass Index of 20-30Kg/m2.
  • 4. Female volunteers and patients must provide evidence that they are not pregnant or lactating, or that they are post-menopausal. A urine pregnancy test (ß-hCG) will be performed on visit 1 if no other credible evidence, such as sterilisation or post-menopausal status is given. Confirmation of the use of adequate birth control will be required in pre-menopausal women that give no evidence of an inability to become pregnant.Male volunteers will be requested to use contraception for the duration of their involvement in the trial, and for one week afterwards.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.People with a previous allergic reaction to radio-contrast media,Iodine or shellfish.
  • 2.People with known thyroid disease, myaesthenia gravis, cardiac arrhythmias, pulmonary hypertension, epilepsy, structural cerebral disease, phaeochromocytoma, advanced heart failure, sickle cell disease, multiple myeloma or homocystinuria.
  • 3.Those in whom Iohexol could interact with their current medications (Metformin if serum creatinine >150µmol/L, Phenothiazines, Tricyclic antidepressants, Monoamine oxidase inhibitors, Levo-thyroxine, Amiodarone, Interleukin-2 agents)
  • 4.People due to undergo an imaging scan using Tc99m –labelled agents within two weeks of the study; Iohexol can interfere with the measurement of Tc99m.
  • 5.Patients on renal replacement therapy.
  • 6.Individuals with a BMI outside the range 20-30Kg/m2
  • 7.Individuals with ascites
  • 8.Pregnant or breast-feeding women.
  • 9.People who are unable to provide Informed Consent.

研究者

相似试验